Status:
UNKNOWN
Cervical Cancer Screening Strategies
Lead Sponsor:
Lei Li
Conditions:
Cervical Cancer
Cervical Intraepithelial Neoplasia
Eligibility:
FEMALE
18+ years
Brief Summary
This study is to investigate retrospectively the results of cervical cytology and high-risk human papillomavirus in the past 20 years recorded in Peking Union Medical College Hospital. The histologica...
Eligibility Criteria
Inclusion
- Aged 18 years or older
- With definite cervical histology after cervical cancer screening, ore with at least one screening test after first testing
Exclusion
- \- Not meeting all of the inclusion criteria
Key Trial Info
Start Date :
March 19 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 19 2025
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT05309122
Start Date
March 19 2022
End Date
March 19 2025
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lei Li
Beijing, Beijing Municipality, China, 100730